Trial intelligence / Profile preview

Growth hormone replacement and cortisol-cortisone interconversion in hypopituitary patients with growth hormone deficiency

2009-010918-30Phase 4Completed

Sponsor
Beaumont Hospital Dublin
Start
Mar 2009
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label trial of somatropin in hypopituitarism and growth hormone deficiency (GHD) (2 arms), sponsored by Beaumont Hospital Dublin. Started Mar 2009; status: completed.

02

Drugs

somatropin
03

Conditions

hypopituitarismgrowth hormone deficiency (GHD)

Beyond the preview

Go deeper on 2009-010918-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-010918-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call